Filing Details
- Accession Number:
- 0001209191-20-036360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-12 17:32:59
- Reporting Period:
- 2020-04-13
- Accepted Time:
- 2020-06-12 17:32:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-13 | 75 | $4.03 | 17,767 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-04-15 | 150 | $4.05 | 17,917 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-04-17 | 150 | $4.04 | 18,067 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-04-21 | 150 | $4.03 | 18,217 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-04-23 | 150 | $4.03 | 18,367 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-04-27 | 150 | $4.02 | 18,517 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-04-29 | 150 | $4.01 | 18,667 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-01 | 150 | $4.01 | 18,817 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-05 | 150 | $3.99 | 18,967 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-07 | 150 | $3.97 | 19,117 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-11 | 150 | $4.02 | 19,267 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-13 | 150 | $3.93 | 19,417 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-14 | 75 | $3.81 | 19,492 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-15 | 75 | $3.76 | 19,567 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-18 | 75 | $3.82 | 19,642 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-19 | 75 | $3.78 | 19,717 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-20 | 75 | $3.77 | 19,792 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-21 | 75 | $3.68 | 19,867 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-22 | 75 | $3.61 | 19,942 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-26 | 75 | $3.59 | 20,017 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-27 | 75 | $3.49 | 20,092 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-28 | 75 | $3.34 | 20,167 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-05-29 | 75 | $3.35 | 20,242 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-01 | 75 | $3.45 | 20,317 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-02 | 75 | $3.35 | 20,392 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-03 | 75 | $3.29 | 20,467 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-04 | 75 | $3.31 | 20,542 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-05 | 75 | $3.44 | 20,617 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-08 | 75 | $3.54 | 20,692 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-09 | 75 | $3.48 | 20,767 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020.